青木 一成

Last Update: 2021/06/02 17:46:40

Print

Name(Kanji/Kana/Abecedarium Latinum)
青木 一成/アオキ カズナリ/Aoki, Kazunari
Primary Affiliation(Org1/Job title)
Institute for Frontier Life and Medical Sciences (inFront)/Assistant Professor
Affiliated programs (koza)
Org1 Job title
Graduate School of Medicine Assistant Professor
Graduate School of Medicine Assistant Professor
Contact Address
Type Address(Japanese) Address(English)
Office
Phone
Type Number
Office
Work Experience
Period Organization(Japanese) Organization(English) Job title(Japanese) Job title(English)
-
ORCID ID
https://orcid.org/0000-0003-2172-2195
researchmap URL
https://researchmap.jp/aoki.kazunari.4c
Research Topics
(Japanese)
骨髄微小環境における造血幹前駆細胞および血液がん幹細胞の維持
(English)
The maintenance of hematopoietic stem and progenitor cells and blood cancer stem cells in bone marrow microenvironment
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Kazunari Aoki, Masako Kurashige, Michiko Ichii, Kei Higaki, Tatsuki Sugiyama, Takashi Kaito, Wataru Ando, Nobuhiko Sugano, Takashi Sakai, Hirohiko Shibayama, Akifumi Takaori‐Kondo, Eiichi Morii, Yuzuru Kanakura, Takashi Nagasawa Kazunari Aoki, Masako Kurashige, Michiko Ichii, Kei Higaki, Tatsuki Sugiyama, Takashi Kaito, Wataru Ando, Nobuhiko Sugano, Takashi Sakai, Hirohiko Shibayama, Akifumi Takaori‐Kondo, Eiichi Morii, Yuzuru Kanakura, Takashi Nagasawa Kazunari Aoki, Masako Kurashige, Michiko Ichii, Kei Higaki, Tatsuki Sugiyama, Takashi Kaito, Wataru Ando, Nobuhiko Sugano, Takashi Sakai, Hirohiko Shibayama, Akifumi Takaori‐Kondo, Eiichi Morii, Yuzuru Kanakura, Takashi Nagasawa Identification of CXCL12‐abundant reticular cells in human adult bone marrow Identification of CXCL12‐abundant reticular cells in human adult bone marrow Identification of CXCL12‐abundant reticular cells in human adult bone marrow British Journal of Haematology British Journal of Haematology British Journal of Haematology 2021/04/10 Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60-69 years with myelodysplastic syndrome. Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60-69 years with myelodysplastic syndrome. Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60-69 years with myelodysplastic syndrome. Annals of hematology, 98, 6, 1367-1381 Annals of hematology, 98, 6, 1367-1381 Annals of hematology, 98, 6, 1367-1381 2019/03/11 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation. Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation. Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation, 54, 9, 1471-1481 Bone marrow transplantation, 54, 9, 1471-1481 Bone marrow transplantation, 54, 9, 1471-1481 2019/02/04 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan. Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan. Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 24, 4, 840-848 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 24, 4, 840-848 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 24, 4, 840-848 2017/11/28 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation. Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation. Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation. International journal of hematology, 105, 3, 369-376 International journal of hematology, 105, 3, 369-376 International journal of hematology, 105, 3, 369-376 2016/10/27 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Outcome of allogeneic hematopoietic stem cell transplantation in cases of mature T/NK-cell neoplasms: a single-center retrospective analysis. Outcome of allogeneic hematopoietic stem cell transplantation in cases of mature T/NK-cell neoplasms: a single-center retrospective analysis. Outcome of allogeneic hematopoietic stem cell transplantation in cases of mature T/NK-cell neoplasms: a single-center retrospective analysis. Annals of hematology, 96, 2, 323-326 Annals of hematology, 96, 2, 323-326 Annals of hematology, 96, 2, 323-326 2016/10/20 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study. Leukemia research, 41, 48-55 Leukemia research, 41, 48-55 Leukemia research, 41, 48-55 2015/12/24 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy. Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy. Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy. Journal of hematology & oncology, 8, 102-102 Journal of hematology & oncology, 8, 102-102 Journal of hematology & oncology, 8, 102-102 2015/09/04 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki CXCR4/CXCL12 signaling impacts enamel progenitor cell proliferation and motility in the dental stem cell niche. CXCR4/CXCL12 signaling impacts enamel progenitor cell proliferation and motility in the dental stem cell niche. CXCR4/CXCL12 signaling impacts enamel progenitor cell proliferation and motility in the dental stem cell niche. Cell and tissue research, 362, 3, 633-42 Cell and tissue research, 362, 3, 633-42 Cell and tissue research, 362, 3, 633-42 2015/08/07 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy. Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy. Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy. Blood, 126, 3, 415-22 Blood, 126, 3, 415-22 Blood, 126, 3, 415-22 2015/06/01 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study. Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study. Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study. British journal of haematology, 168, 3, 463-6 British journal of haematology, 168, 3, 463-6 British journal of haematology, 168, 3, 463-6 2014/09/17 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma. Annals of hematology, 93, 7, 1185-91 Annals of hematology, 93, 7, 1185-91 Annals of hematology, 93, 7, 1185-91 2014/02/14 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Successful treatment of high-risk acute promyelocytic leukemia in very elderly patients using all-trans retinoic acid plus reduced-dose idarubicin. Successful treatment of high-risk acute promyelocytic leukemia in very elderly patients using all-trans retinoic acid plus reduced-dose idarubicin. Successful treatment of high-risk acute promyelocytic leukemia in very elderly patients using all-trans retinoic acid plus reduced-dose idarubicin. Annals of hematology, 93, 9, 1621-3 Annals of hematology, 93, 9, 1621-3 Annals of hematology, 93, 9, 1621-3 2014/01/08 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era. The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era. The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era. Acta haematologica, 130, 4, 242-6 Acta haematologica, 130, 4, 242-6 Acta haematologica, 130, 4, 242-6 2013/07/11 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Therapeutic effects of lenalidomide on hemorrhagic intestinal myeloma-associated AL amyloidosis. Therapeutic effects of lenalidomide on hemorrhagic intestinal myeloma-associated AL amyloidosis. Therapeutic effects of lenalidomide on hemorrhagic intestinal myeloma-associated AL amyloidosis. Internal medicine (Tokyo, Japan), 52, 10, 1101-5 Internal medicine (Tokyo, Japan), 52, 10, 1101-5 Internal medicine (Tokyo, Japan), 52, 10, 1101-5 2013/05/15 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Efficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma. Efficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma. Efficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma. Leukemia & lymphoma, 54, 11, 2441-7 Leukemia & lymphoma, 54, 11, 2441-7 Leukemia & lymphoma, 54, 11, 2441-7 2013/04/17 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone. Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone. Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone. International journal of hematology, 97, 2, 272-4 International journal of hematology, 97, 2, 272-4 International journal of hematology, 97, 2, 272-4 2013/01/26 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki [Fatal hepatic failure due to AL amyloidosis in a patient with multiple myeloma]. [Fatal hepatic failure due to AL amyloidosis in a patient with multiple myeloma]. [Fatal hepatic failure due to AL amyloidosis in a patient with multiple myeloma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 53, 11, 1906-10 [Rinsho ketsueki] The Japanese journal of clinical hematology, 53, 11, 1906-10 [Rinsho ketsueki] The Japanese journal of clinical hematology, 53, 11, 1906-10 2012/11/01 Refereed Japanese Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Central nervous system involvement of primary cutaneous diffuse large B cell lymphoma-leg type diagnosed according to the WHO 2008 classification. Central nervous system involvement of primary cutaneous diffuse large B cell lymphoma-leg type diagnosed according to the WHO 2008 classification. Central nervous system involvement of primary cutaneous diffuse large B cell lymphoma-leg type diagnosed according to the WHO 2008 classification. Annals of hematology, 91, 12, 1975-6 Annals of hematology, 91, 12, 1975-6 Annals of hematology, 91, 12, 1975-6 2012/05/17 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Human herpes virus 6-associated myelitis following allogeneic bone marrow transplantation. Human herpes virus 6-associated myelitis following allogeneic bone marrow transplantation. Human herpes virus 6-associated myelitis following allogeneic bone marrow transplantation. Annals of hematology, 91, 10, 1663-5 Annals of hematology, 91, 10, 1663-5 Annals of hematology, 91, 10, 1663-5 2012/03/15 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Leukemic manifestation of blastic plasmacytoid dendritic cell neoplasm lacking skin lesion : a borderline case between acute monocytic leukemia. Leukemic manifestation of blastic plasmacytoid dendritic cell neoplasm lacking skin lesion : a borderline case between acute monocytic leukemia. Leukemic manifestation of blastic plasmacytoid dendritic cell neoplasm lacking skin lesion : a borderline case between acute monocytic leukemia. Journal of clinical and experimental hematopathology : JCEH, 52, 2, 107-11 Journal of clinical and experimental hematopathology : JCEH, 52, 2, 107-11 Journal of clinical and experimental hematopathology : JCEH, 52, 2, 107-11 2012/01/01 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Blastic plasmacytoid dendritic cell neoplasm expressing the CD13 myeloid antigen. Blastic plasmacytoid dendritic cell neoplasm expressing the CD13 myeloid antigen. Blastic plasmacytoid dendritic cell neoplasm expressing the CD13 myeloid antigen. Acta haematologica, 126, 2, 122-8 Acta haematologica, 126, 2, 122-8 Acta haematologica, 126, 2, 122-8 2011/06/24 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Enteropathy-associated T-cell lymphoma type II complicated by autoimmune hemolytic anemia. Enteropathy-associated T-cell lymphoma type II complicated by autoimmune hemolytic anemia. Enteropathy-associated T-cell lymphoma type II complicated by autoimmune hemolytic anemia. Journal of clinical and experimental hematopathology : JCEH, 51, 2, 119-23 Journal of clinical and experimental hematopathology : JCEH, 51, 2, 119-23 Journal of clinical and experimental hematopathology : JCEH, 51, 2, 119-23 2011/01/01 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Systemic follicular lymphoma with massive intestinal involvement with leukemic manifestation. Systemic follicular lymphoma with massive intestinal involvement with leukemic manifestation. Systemic follicular lymphoma with massive intestinal involvement with leukemic manifestation. Journal of clinical and experimental hematopathology : JCEH, 51, 2, 135-40 Journal of clinical and experimental hematopathology : JCEH, 51, 2, 135-40 Journal of clinical and experimental hematopathology : JCEH, 51, 2, 135-40 2011/01/01 Refereed English Research paper(scientific journal) Disclose to all
Kazunari Aoki Kazunari Aoki Kazunari Aoki Acute renal failure associated with systemic polyoma BK virus activation in a patient with peripheral T-cell lymphoma. Acute renal failure associated with systemic polyoma BK virus activation in a patient with peripheral T-cell lymphoma. Acute renal failure associated with systemic polyoma BK virus activation in a patient with peripheral T-cell lymphoma. International journal of hematology, 92, 4, 638-41 International journal of hematology, 92, 4, 638-41 International journal of hematology, 92, 4, 638-41 2010/10/07 Refereed English Research paper(scientific journal) Disclose to all

  • <<
  • >>
Title language:
Misc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
長畑 洋佑, 青木 一成, 平本 展大, 田端 淑恵, 石川 隆之 長畑 洋佑, 青木 一成, 平本 展大, 田端 淑恵, 石川 隆之 周期的な血球減少を経て発症したETP-ALLの1例 周期的な血球減少を経て発症したETP-ALLの1例 臨床血液, 55, 11, 2344-2344 臨床血液, 55, 11, 2344-2344 , 55, 11, 2344-2344 2014/11 Japanese Disclose to all
青木 一成 青木 一成 青木 一成 びまん性大細胞型B細胞リンパ腫における節外病変が予後に与える影響(The prognostic impacts of extra-nodal involvements in diffuse large B-cell lymphoma in the Rituximab era) びまん性大細胞型B細胞リンパ腫における節外病変が予後に与える影響(The prognostic impacts of extra-nodal involvements in diffuse large B-cell lymphoma in the Rituximab era) びまん性大細胞型B細胞リンパ腫における節外病変が予後に与える影響(The prognostic impacts of extra-nodal involvements in diffuse large B-cell lymphoma in the Rituximab era) 神戸市立病院紀要, 52, 63-63 神戸市立病院紀要, 52, 63-63 神戸市立病院紀要, 52, 63-63 2014/03 English Disclose to all
青木 一成 青木 一成 青木 一成 びまん性大細胞型B細胞リンパ腫における末梢血リンパ球数および単球数が予後に与える影響(The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era) びまん性大細胞型B細胞リンパ腫における末梢血リンパ球数および単球数が予後に与える影響(The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era) びまん性大細胞型B細胞リンパ腫における末梢血リンパ球数および単球数が予後に与える影響(The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era) 神戸市立病院紀要, 52, 63-64 神戸市立病院紀要, 52, 63-64 神戸市立病院紀要, 52, 63-64 2014/03 English Disclose to all
長畑 洋佑, 加藤 愛子, 米谷 昇, 数馬 安浩, 竹田 淳恵, 船山 由樹, 山内 寛彦, 青木 一成, 小野 祐一郎, 田端 淑恵, 松下 章子, 今井 幸弘, 石川 隆之 長畑 洋佑, 加藤 愛子, 米谷 昇, 数馬 安浩, 竹田 淳恵, 船山 由樹, 山内 寛彦, 青木 一成, 小野 祐一郎, 田端 淑恵, 松下 章子, 今井 幸弘, 石川 隆之 化学療法中に脳転移しHAART療法のみで縮小を認めたHIV関連NK/T細胞性リンパ腫の1例 化学療法中に脳転移しHAART療法のみで縮小を認めたHIV関連NK/T細胞性リンパ腫の1例 日本リンパ網内系学会会誌, 53, 151-151 日本リンパ網内系学会会誌, 53, 151-151 , 53, 151-151 2013/04 Japanese Disclose to all
青木 一成 青木 一成 高齢者びまん性大細胞型B細胞リンパ腫の治療成績と予後因子の検討 高齢者びまん性大細胞型B細胞リンパ腫の治療成績と予後因子の検討 神戸市立病院紀要, 51, 90-90 神戸市立病院紀要, 51, 90-90 , 51, 90-90 2013/03 Japanese Disclose to all
Nobuhiko Yamauchi, Kazunari Aoki, June Takeda, Yuki Funayama, Aiko Kato, Yuichiro Ono, Sumie Tabata, Akiko Matsushita, Noboru Yonetani, Takayuki Ishikawa Nobuhiko Yamauchi, Kazunari Aoki, June Takeda, Yuki Funayama, Aiko Kato, Yuichiro Ono, Sumie Tabata, Akiko Matsushita, Noboru Yonetani, Takayuki Ishikawa Nobuhiko Yamauchi, Kazunari Aoki, June Takeda, Yuki Funayama, Aiko Kato, Yuichiro Ono, Sumie Tabata, Akiko Matsushita, Noboru Yonetani, Takayuki Ishikawa Prognostic Impact of Serum Soluble Interleukin-2 Receptor Values Just After Completion of R-CHOP in Diffuse Large B-Cell Lymphoma Prognostic Impact of Serum Soluble Interleukin-2 Receptor Values Just After Completion of R-CHOP in Diffuse Large B-Cell Lymphoma Prognostic Impact of Serum Soluble Interleukin-2 Receptor Values Just After Completion of R-CHOP in Diffuse Large B-Cell Lymphoma BLOOD, 120, 21 BLOOD, 120, 21 BLOOD, 120, 21 2012/11 English Research paper, summary (international conference) Disclose to all
田端 淑恵, 倉田 雅之, 竹田 淳恵, 船山 由樹, 山内 寛彦, 青木 一成, 加藤 愛子, 小野 祐一郎, 有馬 浩史, 瀧内 曜子, 永野 誠治, 松下 章子, 今井 幸弘, 石川 隆之, 高橋 隆幸 田端 淑恵, 倉田 雅之, 竹田 淳恵, 船山 由樹, 山内 寛彦, 青木 一成, 加藤 愛子, 小野 祐一郎, 有馬 浩史, 瀧内 曜子, 永野 誠治, 松下 章子, 今井 幸弘, 石川 隆之, 高橋 隆幸 肝アミロイドーシスによる肝不全で死亡した多発性骨髄腫 肝アミロイドーシスによる肝不全で死亡した多発性骨髄腫 臨床血液, 53, 11, 1906-1910 臨床血液, 53, 11, 1906-1910 , 53, 11, 1906-1910 2012/11 Japanese Disclose to all
竹田 淳恵, 船山 由樹, 山内 寛彦, 青木 一成, 加藤 愛子, 小野 祐一郎, 田端 淑恵, 松下 章子, 石川 隆之 竹田 淳恵, 船山 由樹, 山内 寛彦, 青木 一成, 加藤 愛子, 小野 祐一郎, 田端 淑恵, 松下 章子, 石川 隆之 AMLにおけるCD200発現の意義の検討 AMLにおけるCD200発現の意義の検討 臨床血液, 53, 9, 1197-1197 臨床血液, 53, 9, 1197-1197 , 53, 9, 1197-1197 2012/09 Japanese Disclose to all
田端 淑恵, 竹田 淳恵, 船山 由樹, 山内 寛彦, 青木 一成, 加藤 愛子, 小野 祐一郎, 有馬 浩史, 瀧内 曜子, 永野 誠治, 松下 章子, 石川 隆之 田端 淑恵, 竹田 淳恵, 船山 由樹, 山内 寛彦, 青木 一成, 加藤 愛子, 小野 祐一郎, 有馬 浩史, 瀧内 曜子, 永野 誠治, 松下 章子, 石川 隆之 高リスクMDSに対するAzacitidineの治療効果 高リスクMDSに対するAzacitidineの治療効果 臨床血液, 53, 9, 1327-1327 臨床血液, 53, 9, 1327-1327 , 53, 9, 1327-1327 2012/09 Japanese Disclose to all
南出 竜典, 青木 一成, 田端 淑恵, 松下 章子, 石川 隆之 南出 竜典, 青木 一成, 田端 淑恵, 松下 章子, 石川 隆之 Coombs試験陰性Evans症候群 Coombs試験陰性Evans症候群 臨床血液, 53, 8, 792-792 臨床血液, 53, 8, 792-792 , 53, 8, 792-792 2012/08 Japanese Disclose to all
青木 一成, 小野 祐一郎, 田端 淑恵, 松下 章子, 石川 隆之 青木 一成, 小野 祐一郎, 田端 淑恵, 松下 章子, 石川 隆之 低用量プレドニゾロンで寛解に至った抗エリスロポイエチン抗体陽性慢性赤芽球ろう 低用量プレドニゾロンで寛解に至った抗エリスロポイエチン抗体陽性慢性赤芽球ろう 臨床血液, 53, 8, 800-800 臨床血液, 53, 8, 800-800 , 53, 8, 800-800 2012/08 Japanese Disclose to all
竹田 淳恵, 永野 誠治, 小野 祐一郎, 船山 由樹, 山内 寛彦, 青木 一成, 加藤 愛子, 田端 淑恵, 松下 章子, 石川 隆之, 丸岡 隼人 竹田 淳恵, 永野 誠治, 小野 祐一郎, 船山 由樹, 山内 寛彦, 青木 一成, 加藤 愛子, 田端 淑恵, 松下 章子, 石川 隆之, 丸岡 隼人 Triple Hit lymphomaの1例 Triple Hit lymphomaの1例 日本リンパ網内系学会会誌, 52, 116-116 日本リンパ網内系学会会誌, 52, 116-116 , 52, 116-116 2012/05 Japanese Disclose to all
丸岡 隼人, 江藤 正明, 那須 浩二, 老田 達雄, 岸本 健治, 宇佐美 郁哉, 青木 一成, 小野 祐一郎, 加藤 愛子, 有馬 浩史, 瀧内 曜子, 永野 誠治, 田端 淑恵, 柳田 宗之, 松下 章子, 高橋 隆幸, 石川 隆之 丸岡 隼人, 江藤 正明, 那須 浩二, 老田 達雄, 岸本 健治, 宇佐美 郁哉, 青木 一成, 小野 祐一郎, 加藤 愛子, 有馬 浩史, 瀧内 曜子, 永野 誠治, 田端 淑恵, 柳田 宗之, 松下 章子, 高橋 隆幸, 石川 隆之 6カラーフローサイトメトリーによる造血器腫瘍のイムノフェノタイピング 6カラーフローサイトメトリーによる造血器腫瘍のイムノフェノタイピング 神戸市立病院紀要, 50, 15-26 神戸市立病院紀要, 50, 15-26 , 50, 15-26 2012/03 Japanese Disclose to all
松本 健, 大塚 今日子, 永田 一真, 青木 一成, 富井 啓介, 今井 幸弘 松本 健, 大塚 今日子, 永田 一真, 青木 一成, 富井 啓介, 今井 幸弘 閉塞性肺炎を契機に診断された気管支病変主体のNK/T細胞リンパ腫の1例 閉塞性肺炎を契機に診断された気管支病変主体のNK/T細胞リンパ腫の1例 日本呼吸器学会誌, 1, 2, 151-156 日本呼吸器学会誌, 1, 2, 151-156 , 1, 2, 151-156 2012/02 Japanese Disclose to all
永野 誠治, 竹田 淳恵, 船山 由樹, 山内 寛彦, 青木 一成, 小野 祐一郎, 加藤 愛子, 有馬 浩史, 瀧内 曜子, 田端 淑恵, 松下 章子, 石川 隆之 永野 誠治, 竹田 淳恵, 船山 由樹, 山内 寛彦, 青木 一成, 小野 祐一郎, 加藤 愛子, 有馬 浩史, 瀧内 曜子, 田端 淑恵, 松下 章子, 石川 隆之 Double Ph cloneが確認されたCMLに対しダサチニブを使用した1例 Double Ph cloneが確認されたCMLに対しダサチニブを使用した1例 臨床血液, 53, 1, 124-125 臨床血液, 53, 1, 124-125 , 53, 1, 124-125 2012/01 Japanese Disclose to all
永野 誠治, 青木 一成, 小野 祐一郎, 加藤 愛子, 有馬 浩史, 瀧内 曜子, 田端 淑恵, 柳田 宗之, 松下 章子, 石川 隆之 永野 誠治, 青木 一成, 小野 祐一郎, 加藤 愛子, 有馬 浩史, 瀧内 曜子, 田端 淑恵, 柳田 宗之, 松下 章子, 石川 隆之 大顆粒リンパ球性白血病に合併した赤芽球癆によるヘモクロマトーシスに行った鉄キレート療法 大顆粒リンパ球性白血病に合併した赤芽球癆によるヘモクロマトーシスに行った鉄キレート療法 臨床血液, 52, 8, 742-742 臨床血液, 52, 8, 742-742 , 52, 8, 742-742 2011/08 Japanese Disclose to all
青木 一成, 瀧内 曜子, 柳田 宗之, 石川 隆之, 橋本 尚子 青木 一成, 瀧内 曜子, 柳田 宗之, 石川 隆之, 橋本 尚子 同種移植後に脳炎症状を呈さず発症したSIADHにおいて髄液中のHHV6再活性化が原因と考えられた1例 同種移植後に脳炎症状を呈さず発症したSIADHにおいて髄液中のHHV6再活性化が原因と考えられた1例 臨床血液, 52, 8, 746-746 臨床血液, 52, 8, 746-746 , 52, 8, 746-746 2011/08 Japanese Disclose to all
多田 朋弥, 青木 一成, 静田 聡, 塩井 哲雄, 尾野 亘, 木村 剛, 北 徹 多田 朋弥, 青木 一成, 静田 聡, 塩井 哲雄, 尾野 亘, 木村 剛, 北 徹 PCI施行後に気腫性胆嚢炎をきたした1例 PCI施行後に気腫性胆嚢炎をきたした1例 Circulation Journal, 73, Suppl.II, 959-959 Circulation Journal, 73, Suppl.II, 959-959 , 73, Suppl.II, 959-959 2009/04 Japanese Disclose to all

  • <<
  • >>
Title language:
Awards
Title(Japanese) Title(English) Organization name(Japanese) Organization name(English) Date
日本骨髄腫学会奨励賞 日本骨髄腫学会 2021/05/29
第82回日本血液学会学術集会優秀ポスター賞 82nd Annual Meeting of the Japanese Society of Hematology Best Poster Award 日本血液学会 the Japanese Society of Hematology 2020/10/10
日本白血病研究基金臨床医学特別賞 日本白血病研究基金 2015/11/
日本血液学会奨励賞 日本血液学会 2015/10/
米国血液学会Abstract Achievement Award American Society of Hematology Abstract Achievement Award 米国血液学会 American Society of Hematology 2012/12/
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
基盤研究(C) Representative CXCL12-CXCR4軸による造血幹細胞制御に必須の細胞内分子の網羅的探索 2021/04/01-2024/03/31
External funds: other than those above
System Main person Title(Japanese) Title(English) Period
日本骨髄腫学会奨励賞・研究助成 青木 一成 CXCL12-CXCR4軸による骨髄腫細胞制御に必須の細胞内分子の網羅的探索 2021/05/29-2022/03/31
2020年度第II期京都大学若手研究者スタートアップ研究費 青木一成 CXCL12-CXCR4軸による造血幹細胞制御に必須の細胞内分子の網羅的探索 2020/10/01-2021/03/31
2020年度第I期京都大学若手研究者スタートアップ研究費 青木 一成 MMSETを過剰発現する多発性骨髄腫の生体内での病態形成機構・増殖機構の解明 2020/04/01-2020/09/30